YU44998B - Process for obtaining 2-oxindole-1-carboxamide compound - Google Patents

Process for obtaining 2-oxindole-1-carboxamide compound

Info

Publication number
YU44998B
YU44998B YU730/85A YU73085A YU44998B YU 44998 B YU44998 B YU 44998B YU 730/85 A YU730/85 A YU 730/85A YU 73085 A YU73085 A YU 73085A YU 44998 B YU44998 B YU 44998B
Authority
YU
Yugoslavia
Prior art keywords
oxindole
obtaining
carboxamide compound
carboxamide
compound
Prior art date
Application number
YU730/85A
Other languages
English (en)
Other versions
YU73085A (en
Inventor
S B Kadin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of YU73085A publication Critical patent/YU73085A/xx
Publication of YU44998B publication Critical patent/YU44998B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/60Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/70[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
YU730/85A 1984-05-04 1985-04-30 Process for obtaining 2-oxindole-1-carboxamide compound YU44998B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60735684A 1984-05-04 1984-05-04

Publications (2)

Publication Number Publication Date
YU73085A YU73085A (en) 1988-04-30
YU44998B true YU44998B (en) 1991-06-30

Family

ID=24431933

Family Applications (1)

Application Number Title Priority Date Filing Date
YU730/85A YU44998B (en) 1984-05-04 1985-04-30 Process for obtaining 2-oxindole-1-carboxamide compound

Country Status (25)

Country Link
JP (1) JPS60243068A (cs)
KR (1) KR870000497B1 (cs)
AR (1) AR241159A1 (cs)
BG (2) BG60208B2 (cs)
CS (1) CS252828B2 (cs)
DD (1) DD232916A5 (cs)
EG (1) EG17193A (cs)
ES (2) ES8609248A1 (cs)
FI (1) FI80016C (cs)
HU (1) HU196057B (cs)
IE (1) IE851103L (cs)
IN (1) IN161509B (cs)
MA (1) MA20424A1 (cs)
MW (1) MW1685A1 (cs)
MX (1) MX5839A (cs)
NO (1) NO163132C (cs)
OA (1) OA08098A (cs)
PL (2) PL145416B1 (cs)
PT (1) PT80375B (cs)
RO (2) RO94455B (cs)
RU (1) RU2017729C1 (cs)
SU (1) SU1468413A3 (cs)
YU (1) YU44998B (cs)
ZA (1) ZA853324B (cs)
ZW (1) ZW7885A1 (cs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
IL95880A (en) * 1989-10-13 1995-12-31 Pfizer Use of 3-Transformed History of 2-Oxindole for the Preparation of Pharmaceuticals for Inhibition of Interlaukio-1 Biosynthesis

Also Published As

Publication number Publication date
RO94455B (ro) 1988-07-01
HUT37754A (en) 1986-02-28
MW1685A1 (en) 1986-09-10
CS252828B2 (en) 1987-10-15
YU73085A (en) 1988-04-30
FI80016C (fi) 1990-04-10
PL145416B1 (en) 1988-09-30
PL257892A1 (en) 1986-10-07
BG60208B2 (en) 1993-12-30
IN161509B (cs) 1987-12-19
RO94455A (ro) 1988-06-30
FI851756L (fi) 1985-11-05
ES8609248A1 (es) 1986-07-16
AR241159A1 (es) 1991-12-30
ZA853324B (en) 1986-12-30
CS320285A2 (en) 1987-03-12
NO163132C (no) 1990-04-11
PT80375A (en) 1985-05-01
KR850008154A (ko) 1985-12-13
JPH0335315B2 (cs) 1991-05-27
PL147508B1 (en) 1989-06-30
MX5839A (es) 1993-11-01
AR241159A2 (es) 1991-12-30
ZW7885A1 (en) 1985-07-24
HU196057B (en) 1988-09-28
RO91141A (ro) 1987-06-30
JPS60243068A (ja) 1985-12-03
DD232916A5 (de) 1986-02-12
RO91141B (ro) 1987-07-03
KR870000497B1 (ko) 1987-03-12
RU2017729C1 (ru) 1994-08-15
EG17193A (en) 1990-08-30
NO851774L (no) 1985-11-05
MA20424A1 (fr) 1985-12-31
FI80016B (fi) 1989-12-29
ES551275A0 (es) 1987-07-16
BG60207B2 (en) 1993-12-30
OA08098A (fr) 1987-03-31
PL253203A1 (en) 1986-06-17
IE851103L (en) 1985-11-04
ES542813A0 (es) 1986-07-16
FI851756A0 (fi) 1985-05-03
PT80375B (pt) 1987-09-30
NO163132B (no) 1990-01-02
SU1468413A3 (ru) 1989-03-23
ES8707182A1 (es) 1987-07-16

Similar Documents

Publication Publication Date Title
YU197385A (en) Process for stabilizing nicorandyl compound
PT81225A (en) Process for preparing triazoloquinazoline compounds
YU200985A (en) Process for producing acilated diketonic compounds
YU62385A (en) Process for obtaining 9a-aza-9a-homoeritromicyn derivatives
HUT38339A (en) Process for producing dihydropyridine-carbonyl compounds
YU45251B (en) Process for obtaining hydroxi-4-2h-1-benzothiopyran-2 one
PT80663B (en) Process for preparing epoxysteroids
HUT38942A (en) Process for preparing substituted 7-oxo-mitosanes
YU69785A (en) Process for obtaining l-carnityne
HUT38952A (en) Process for 16alpha-metylation
GB2175583A (en) Process for preparing n-acylphenylalanines
EP0165595A3 (en) Process for preparing 5-deoxy-l-arabinose
YU64385A (en) Process for preparing bis-chinazolinic compounds
IL76816A (en) Process for preparing 13-hydroxy-5-ketomilbemycin
GB2183670B (en) Process for self-hydrogenation
GB2167752B (en) Process for synthesizing diorganomonothiophosphinates
GB2161802B (en) Process for producing n-chlorosulfenyl compounds
PT80816B (en) Process for preparing pyridazinylimidazolidinone compounds
YU73085A (en) Process for obtaining 2-oxindole-1-carboxamide compound
YU6185A (en) Process for obtaining phenoxi-benzaldeniodic derivatives
YU102587A (en) Process for obtaining substituted ethandiimidamides
GB2162839B (en) Process for preparing aminobenzylamine
DE3564569D1 (en) Process for preparing 2-alkyl-5-haloacetylbenzenesulfonamide
DE3563448D1 (en) Process for preparing polyphenylenethers
PT81555A (en) Process for preparing substituted dioxolonaphtopyran compounds